For decades, managing serious mental conditions such as schizophrenia or bipolar disorder has often come with a physical price: rapid weight gain.

Doctors long blamed the problem on powerful antipsychotic medications. But the exact reason — that is, why people on those drugs develop bigger waistlines, even prediabetes — defied a concrete explanation.

Now researchers in Pittsburgh have an answer, according to a paper published last month. And they hope the findings will help drug developers refine better treatments — with fewer burdens on physical health.

“At least we’re starting to get a glimpse of why this is happening,” said lead author Despoina Aslanoglou, a postdoctoral fellow at the University of Pittsburgh School of Medicine, referring to dysfunction in patients’ metabolism.

Advertise with us

The study found antipsychotics affect dopamine’s function not only in the brain — where the drugs are meant to work — but also in the pancreas. Dopamine is a natural chemical that helps the brain communicate with the body.

By blocking dopamine signaling in the pancreas, antipsychotics effectively allow “uncontrolled production” of key hormones and lead to obesity and diabetes, according to Pitt’s overview of the study findings.

Senior author Dr. Zachary Freyberg has worked more than a decade to investigate the side effects, “to understand at a very fundamental level” how the antipsychotic drugs affect dopamine activity.

“People start and stop medications all the time because they can’t tolerate them,” said Dr. Freyberg, an assistant professor of psychiatry and cell biology at Pitt. The pattern leads to relapse and renewed efforts to control symptoms, he said.

Weight gain and metabolic side effects in particular appear as big reasons why patients halt taking the medications, according to earlier research cited by Dr. Freyberg. Prescribing doctors aren’t always well versed in those side effects, he said.

Advertise with us

The drugs “can be life-saving because they reduce severe depression; they help stabilize mood; they help reduce debilitating hallucinations — for examples,” Dr. Freyberg said. “All these things are incredibly powerful and a force for good, which is why they’ve been around as long as they have been.”

For Susan Brown Padilla, 53, antipsychotic medication helps her focus as she faces “nerve-racking voices or things I see.”

“It’s overwhelming. It’s very difficult to concentrate,” said Ms. Padilla, who was diagnosed with schizophrenia. “The medication helps me concentrate on things I would rather focus on — rather than allow myself to be consumed with that aspect of my circumstances.”

But she suspects her arthritis would ease, and that she would feel less pain, if she could lose 60 to 70 pounds, said Ms. Padilla, a senior peer specialist at UPMC Western Psychiatric Hospital. “That would enhance the quality of life, certainly.”

Even regular trips to the gym didn’t knock down her weight, she said, fearing her medication “messes with my metabolism.”

Advertise with us

“Some of those risks shouldn’t be there,” Ms. Padilla said. “People could apply themselves a little more to come up with different medications that would not impact the body so strongly.”

Ms. Aslanoglou voiced a similar hope, saying she would like to see the study findings influence advancements in drug discoveries. Around 1% of any given population suffers from psychosis — people who are often prescribed antipsychotics, she said.

“Understanding how something works is the first step to understanding how to improve on it,” said Dr. Freyberg, who sees hope for the reformulation of drugs.

In the meantime, it’s important for clinicians to monitor effects closely in patients who take antipsychotics and to establish a strong baseline for key gauges of their health, such as weight and nutrition, Dr. Freyberg said.

“At the same time, be proactive. Work with a nutritionist,” he said. “Emphasize eating habits and exercise.”

Other authors of the research, which appears in the journal Translational Psychiatry, include Dr. Massimo Trucco, Suzanne Bertera and Rita Bottino at the Allegheny Health Network Research Institute as well as experts at the National Institutes of Health, Vanderbilt University and the University of Geneva.